Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez, Yusheng Zhang, Yuichiro Nakata, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 331

Showing 1-25 of 331 citing articles:

Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
Misung Park, Do‐Hee Kim, Sunghyub Ko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6806-6806
Open Access | Times Cited: 211
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Léa Clusan, François Ferrière, Gilles Flouriot, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6834-6834
Open Access | Times Cited: 154
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
The role of epigenetic modifications in drug resistance and treatment of breast cancer
Mohsen Karami Fath, Ali Azargoonjahromi, Arash Kiani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 85
Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
Feng Shu, Xiao Han, Qiu-Nuo Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies
Shu Yang, Xiaomin Wang, Xintong Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114698-114698
Open Access | Times Cited: 42
Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
Laura López-González, Alicia Sánchez Cendra, Cristina Sánchez Cendra, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 168-168
Open Access | Times Cited: 17
Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study
Banafsheh Honarvari, Sara Karimifard, Niyayesh Akhtari, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4634-4634
Open Access | Times Cited: 58
Chitosan: A versatile bio-platform for breast cancer theranostics
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 733-752
Closed Access | Times Cited: 56
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer
Maria Beatriz Madureira, Virgínia Márcia Concato, Ellen Mayara Souza Cruz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 35
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 33
Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics
Fengyun Zhong, Yilin Lin, Long Zhao, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 24-37
Open Access | Times Cited: 31
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
Sandra Kannampuzha, Abilash Valsala Gopalakrishnan
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 26
Clinical applications of deep learning in breast MRI
Xue Zhao, Jing‐Wen Bai, Qiu Guo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 2, pp. 188864-188864
Closed Access | Times Cited: 25
Design, Synthesis, and Biological Evaluation of a Potent Dual EZH2–BRD4 Inhibitor for the Treatment of Some Solid Tumors
Niannian Huang, Ping Liao, Yunxia Zuo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2646-2662
Closed Access | Times Cited: 23
Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
Snehal Nimal, Navanath Kumbhar, Saruchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway
Zheqiong Tan, Keerti Boyapati, Caitlin M. Tressler, et al.
Cancer Letters (2024) Vol. 586, pp. 216653-216653
Closed Access | Times Cited: 13
Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma
Jie Chen, Qimin Zhou, Shuai Li, et al.
Translational research (2024) Vol. 268, pp. 28-39
Closed Access | Times Cited: 12
Insights into molecular mechanisms of chemotherapy resistance in cancer
Animesh Kar, Shivam Agarwal, Agrata Singh, et al.
Translational Oncology (2024) Vol. 42, pp. 101901-101901
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top